This information was last updated on April

New Post Public Reply Private Reply Replies (0) Message Board
Badali

This information was last updated on April 22, 2013 and should be considered current as of that date.

When was Organovo founded?

Organovo, Inc. was incorporated in 2007 to advance bioprinting technology and began its operations in San Diego, California in January 2009. Read more about our company's history .

When did Organovo become publicly traded?

The common stock of Organovo Holdings, Inc. became publicly traded on February 14, 2012 .

Where are Organovo shares traded and what is the ticker symbol?

Organovo’s common stock is publicly traded on the highest OTC Markets tier, OTCQX, under the symbol ONVO .

What is Organovo's CUSIP?

Our CUSIP is 68620A 10 4.

What is the relationship between Organovo Holdings, Inc. and Organovo, Inc.?

Organovo, Inc. has been an operating company in San Diego, California since 2009 and currently operates as a fully owned subsidiary of Organovo Holdings, Inc.  As a vehicle to provide capital for Organovo, Inc. operations and to provide access to public markets for equity securities, Organovo, Inc. entered into a reverse merger with Organovo Holdings, Inc. in February, 2012 concurrent with a private placement financing. Organovo Holdings, Inc. was a publicly traded shell company before completion of the reverse merger.  Upon effectiveness of the reverse merger, former officers and directors of Organovo Holdings, Inc. resigned their positions and officers and directors associated with Organovo, Inc. assumed control of Organovo Holdings, Inc. In aggregate, approximately $15.2 million was raised in the private placement .

Can I purchase shares directly from Organovo?

No. You may purchase Organovo’s common stock through a registered brokerage or stock purchase service provider of your choice. Further information about investing in OTC securities can be found on the OTC Markets website .

How many shares are outstanding?

Approximately 64.7 million shares of common stock are issued and outstanding.  Organovo has not issued any shares of preferred stock.

Where can I find Organovo’s most recent financials?

Audited financial statements for the year ended December 31, 2012 can be found in the form 10-K filed with the SEC on March 15, 2013.

When does Organovo report earnings? How can I listen to the webcast for the earnings report?

We report earnings on or before the dates required by the SEC (view  the SEC calendar [PDF]). To stay informed about our SEC filings and press releases, please sign up for email alerts.

Where can I find Organovo's SEC filings?

You can access all our filings through the Financial Reports section of this website or on the SEC website .

What is Organovo’s policy on dividends?

We do not pay a dividend on stock, and do not foresee doing so in the immediate future.

What is Organovo’s fiscal year-end?

Our fiscal year-end is March 31.

Who are Organovo’s independent Auditors?

Our auditors are Mayer Hoffman McCann P.C.

What firm serves as Organovo’s Legal Counsel?

DLA Piper US, LLP serves as Organovo's legal counsel.

Where can I find a list of Organovo’s Board of Directors?

Please see this page for our  Board of Directors .

Who is Organovo’s transfer agent?

V Stock Transfer . They can be reached at 1-212-828-8436.

What is a transfer agent?

The transfer agent is responsible for maintaining all records of registered stockholders (including change of address, telephone number and name), canceling or issuing stock certificates and resolving problems related to lost, destroyed or stolen certificates. If your shares are held in street name (i.e. by your broker), you must contact your broker for these services.

I’ve lost my stock certificates. How can I replace them?

If you have lost a stock certificate, you should contact our transfer agent, V Stock Transfer , immediately so that they may place a "stop" on the form of certificate. Once the "stop" is placed, you may need to complete a "lost instrument bond" form. You can contact the transfer agent at 1-212-828-8437. Please note that surety bonds are typically required by transfer agents to replace lost, stolen, or damaged stock certificates.

What should I do if my address has changed?

If your shares are held in your name, you may contact V Stock Transfer , Organovo’s Transfer Agent, at 1-212-828-8437. If your shares are held in street name (by your broker), contact your broker to update your address.

Where is Organovo headquartered?

Organovo is headquartered in San Diego, California.

Can I tour Organovo’s facility?

Our introductory video provides representative exterior and interior views of our San Diego facility, and provides a view of our NovoGen Bioprinter™ in operation.  The cleanroom environment in which our bioprinters operate renders tours impractical. Moreover, access to our laboratories is limited to individuals with adequate safety and GLP training.

How can I stay informed about Organovo?

You can sign up for email alerts and follow us on Twitter ( @Organovo ).

Who can I contact if I have a question that hasn’t been answered here?

Contact our investor relations team by  submitting this form .

Organovo Holdings, Inc. (ONVO) Stock Research Links

ONVO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CME Group Smashes FX Open Interest Record Again

Updated Category News Views 3

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Continue Reading
vivo and UNESCO Unite Youth for Nature Stories

Updated Category News Views 6

Young Creators Explore Nature Through a New Lens Pontremoli, Italy just became the backdrop for an extraordinary gathering of young visionaries. From August 31 to September 5, UNESCO’s Man and the Biosphere (MAB) Programme and vivo wrapped their 2026 Capture the Future initiative in the lush landscapes of the Appennino Tosco Emiliano Biosphere Reserve. It’s one thing...

Continue Reading
York Space Systems Faces Investor Lawsuit Over Claims

Updated Category News Views 1

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...

Continue Reading
Montana Dreams: Faith in New Beginnings

Updated Category News Views 18

Kickstart into a Faith-Fueled Tale Out of Lillington, N.C. comes a novel that isn't just pages of printed text, but almost a life lesson wrapped in fiction. Lee Jennings serves up "Home in Montana," a Christian romance mystery that throws a kaleidoscope of emotions onto the reader's lap, whether they're relaxed in a recliner or flipping through it on their lunch break....

Continue Reading
Six Flags Offers Flexible Payment Plan with Flex Pay

Updated Category News Views 6

New Payment Option Brings Flexibility Seems like Six Flags isn't just about roller coasters anymore—now they're playing the long game with wallet-friendly options. Flex Pay by Upgrade is the latest spin on season pass financing, letting guests divvy up payments and kickstart their amusement park fun right away. This move could be a game-changer for folks looking to lock...

Continue Reading
Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Updated Category News Views 6

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Continue Reading
La Compagnie Unveils NYC-Düsseldorf Flight Plans

Updated Category News Views 2

A new chapter is unfolding in the skies over the Atlantic. La Compagnie is gearing up to connect New York to Düsseldorf with a direct, all-business-class flight starting in Spring 2027. This move is ambitious, tapping into the bustling economic energy present across the North Rhine-Westphalia region—an economic powerhouse littered with U.S.-affiliated businesses. A...

Continue Reading
Automotive ECU Market Aims $160B by 2033

Updated Category News Views 4

Automotive ECUs Under the Spotlight Picture this: By 2033, the automotive ECU market is expected to balloon to a whopping $160.59 billion. That's some serious cash, and it ain't just pocket change. This $47 billion jump from 2026 isn't just happening by accident—it's got everything to do with high-octane changes in the industry. With a 5.1% CAGR, you best believe it's a...

Continue Reading
AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Updated Category News Views 4

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Continue Reading
Frost & Sullivan's Bold Subscription Move Signals Growth

Updated Category News Views 1

New Leadership Steers Strategic Growth Just when you thought the subscription game couldn't get more interesting, in steps Janesh Janardhanan. Frost & Sullivan, the big brain of analytics and growth advice, has handed him the reins of their fancy subscriptions portfolio. Janardhanan's job? To pump some muscle into their global growth and ensure their analytics and...

Continue Reading

Top 5 Most Recently Viewed Articles

Charter Communications Secures Significant $2 Billion Notes Deal

Updated Category News Views 96

Charter Communications Announces $2 Billion Notes Offering Charter Communications, Inc. (NASDAQ: CHTR) is excited to announce the successful completion of a significant financial milestone. The company, along with its subsidiaries Charter Communications Operating, LLC and Charter Communications Operating Capital Corp, has closed an offering of $2.0 billion in aggregate...

Continue Reading
Experience the 2025 Mazda3 Hatchback at Flagship Mazda Today

Updated Category News Views 98

Introducing the 2025 Mazda3 Hatchback Flagship Mazda is thrilled to announce that the highly anticipated 2025 Mazda3 Hatchback is now available. This vehicle perfectly combines attractive design, refined performance, and state-of-the-art technology into a compact package that caters to modern drivers. Dynamic Design and Comfort The design of the 2025 Mazda3 Hatchback is...

Continue Reading
Trigon Property Development's Recent Financial Performance Overview

Updated Category News Views 193

Trigon Property Development's Business Focus Trigon Property Development AS is dedicated to shaping the landscape of real estate development. As of the end of September 2025, the company is actively engaged in a development project that spans 13.2 hectares in Estonia. The vision for this area includes creating a vibrant commercial, industrial, and logistics park. The...

Continue Reading
ResMed's Growth Plans Highlighted At Recent Investor Event

Updated Category News Views 61

ResMed (NYSE: RMD) held an investor day a while back where they threw down some big plans. They set their sights on reaching a whopping 500 million patients by 2030—sounds ambitious, right? The focus was all about playing with the latest tech in wearables and GLP-1 therapies to boost treatment options for folks with sleep and breathing issues. The talk of acquisitions...

Continue Reading
Thermo Fisher Enhances Cell Therapy with New Dynabeads CD4 and CD8

Updated Category News Views 130

Introduction to CTS Detachable Dynabeads Thermo Fisher Scientific Inc. has recently launched innovative products aimed at enhancing the development and production of cell therapies. The new Gibco™ CTS™ Detachable Dynabeads™ CD4 and CTS Detachable Dynabeads CD8 offer cutting-edge solutions that prioritize cell quality and streamline the workflow for cell therapy...

Continue Reading